You are here: Industry Insights > Covaxin

News List

More pharma companies should be permitted to produce COVID-19 vaccines: Gadkari expresspharma
May 19, 2021
Instead of one company, 10 more companies should be allowed to make vaccines by paying 10 per cent royalty to the original patent holder of the vaccine, he said.
Gujarat Government, Hester Biosciences and Omnibrx to collaborate for COVAXIN production expresspharma
May 17, 2021
Hester Biosciences has entered into a tie-up with Gujarat Biotechnology Research Centre, Department of Science & Technology, Government of Gujarat; and with Omnibrx; to manufacture Covaxin.
Over two billion doses of COVID-19 vaccines to be available between August to December 2021: Centre expresspharma
May 14, 2021
The Centre said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
SEC recommends phase II/III clinical trials of Covaxin on 2-18 year-olds expresspharma
May 13, 2021
The trial will be conducted on 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Parliamentary panel had recommended ramping up vaccine manufacturing capacity in March expresspharma
May 13, 2021
The recommendations made by the 31-member committee that reportedly had as many as 14 members from the ruling BJP was tabled in Parliament on March 8.
Bharat Biotech begins direct supply of COVAXIN to 14 states expresspharma
May 11, 2021
The firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government.
Tech transfers, collaborations, materials supply key to scale up vaccine manufacturing: Suchitra Ella expresspharma
May 10, 2021
Bharat Biotech is in the process of ramping up the manufacturing capacity of Covaxin to 70 crore dosages per annum.
SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine expresspharma
May 07, 2021
The company's response came after the Health Ministry in a statement refuted the allegations that it has not placed any fresh orders for the Covishield vaccine with SII.
Covaxin prices slashed from Rs 600 to Rs 400 per dose for states expresspharma
April 30, 2021
The announcement came one day after the Serum Institute of India, reduced the price of Covishield from ₹400 to ₹300.
Bharat Biotech, ICMR announce interim results from Phase 3 trials of COVAXIN expresspharma
April 22, 2021
Bharat Biotech announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based on accruing more than 87 symptomatic cases of COVID-19. Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a ...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page